Approval · Notice of Compliance 19009 · 2017
LACTIFENCE: Notice of Compliance 19009
Issued February 28, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19009
- Date
- February 28, 2017
- Company
- DeLaval, Inc.Ville D'Anjou, Quebec, Canada
- Product type
- Veterinary
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LACTIFENCE | 02461978 | Marketed |
Medicinal ingredients
- LACTIC ACID 3.5 PER